Compliance, competition could be speed breakers Viveka Roychowdhury Oct 3, 2024 As India positions itself as part of the China+plus one strategy, China has a counter strategy: dumping of low cost imports and…
Ind-Ra forecasts weak API prices and volume growth for India in FY25 EP News Bureau Sep 23, 2024 Decline in raw material costs and forward integration into formulations business help mitigate impact on margins
Drug shortage in the US to prove beneficial for Indian pharma companies Ind-Ra May 28, 2024 US-focused pharma companies to sustain their revenue improvement trend in FY25 on account of heightened drug shortages in the US…
